Accelerated biological aging, which involves the gradual decline of organ or tissue functions and the distortion of physiological processes, underlies several human diseases. Away from the earlier free radical concept, telomere attrition, cellular senescence, proteostasis loss, mitochondrial dysfunction, stem cell exhaustion, and epigenetic and genomic alterations have emerged as biological hallmarks of aging. Moreover, nutrient-sensing metabolic pathways are critical to an organism’s ability to sense and respond to nutrient levels. Pharmaceutical, genetic, and nutritional interventions reverting physiological declines by targeting nutrient-sensing metabolic pathways can promote healthy aging and increase lifespan. On this basis, biological aging hallmarks and nutrient-sensing dependent and independent pathways represent evolving drug targets for many age-linked diseases. Here, we discuss and update the scientific community on contemporary advances in how dietary supplements and natural products beneficially revert accelerated biological aging processes to retrograde human aging and age-dependent human diseases, both from the clinical and preclinical studies point-of-view. Overall, our review suggests that dietary/natural products increase healthspan - rather than lifespan – effectively minimizing the period of frailty at the end of life. However, real-world setting clinical trials and basic studies on dietary supplements and natural products are further required to decisively demonstrate whether dietary/natural products could promote human lifespan.

In recent years, the spread of the coronavirus disease 2019 (COVID-19) in China has been effectively controlled by implementing national prevention and control measures. However, a large number of recovered patients are plagued by fatigue, whether acute or chronic, and other fatigue-related syndromes that severely affect their quality of life. Post-viral fatigue syndrome (PVFS) is a widespread chronic neurological disease with no definite etiological factor(s), definitive diagnostic test, or approved pharmacological treatment, therapy, or cure. In this study, we performed a bibliometric analysis and the results suggested that neuroinflammation played a role in the development of PVFS. Therefore, we briefly analyzed the mechanisms underlying the development of neuroinflammation in patients with COVID-19. To identify effective drugs to alleviate PVSF, we summarized four traditional herbal phytoadaptations and discussed their molecular mechanisms in improving neurological fatigue. Our study showed that ginseng, Acanthopanax, Rhodiola, and Schisandra played beneficial roles in alleviating PVSF. Graphical http://links.lww.com/AHM/A45.